Cbd Dominant Genetics

CBD-dominant genetics refer to cannabis cultivars bred to express higher cannabidiol (CBD) levels relative to THC, typically with ratios of 1:1 or higher CBD-to-THC, or CBD-only phenotypes. These strains emerged through selective breeding programs targeting the CBDA synthase enzyme pathway, with foundational work often traced to Swiss breeding initiatives in the early 2000s and subsequent European and North American programs. Breeders working in this category frequently cross high-CBD parent plants or backcross to stabilize recessive CBD-expressing traits. The genetic architecture involves multiple loci, making CBD expression inconsistent across seed runs unless stabilized through inbreeding or cloning programs. CBD-dominant genetics have become a significant breeding focus due to regulatory frameworks in many jurisdictions that distinguish cannabis by cannabinoid profile rather than pla

Breeders use CBD-dominant genetics as foundation stock for pharmaceutical, nutraceutical, and legal consumer product lines, combining them with terpene-rich or morphologically desirable parents to create commercially viable cultivars. Stabilizing CBD expression requires multi-generational selection and often F2 or F3 testing to identify homozygous or reliably heterozygous genotypes.